Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


US okays protocol for PNT (Pneumatic Trabeculoplasty) glaucoma therapy study:

This article was originally published in Clinica

Executive Summary

Coronado Industries is pressing ahead with efforts to gather data to support a US marketing application for its non-invasive pneumatic device for treating glaucoma, after receiving FDA approval for its study protocol. The Pneumatic Trabeculoplasty (PNT) device, which is already CE-marked for sale in Europe, works by applying suction to the eye for two minutes to reduce intraocular pressure. The Fountain Hills, Arizona firm says it is working with Novartis on an agreement covering exclusive global licensing and distribution rights to the product.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts